I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm
The arm of this study evaluates possible GABA-A receptor target engagement effects of the FDA-approved medication, transdermal flumazenil (added 4/2020, replaced clarithromycin), in the setting of Parkinson's disease. Half of the subjects will receive transdermal flumazenil for 7-10 days, and half will receive a placebo. [11C]Flumazenil GABA-A receptor PET imaging …
cochlear implant
stroke
spinal cord
modafinil
benztropine
- 0 views
- 19 Feb, 2024
Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients
The purpose of this study is to evaluate the safety and efficacy of BiRd regimen combined with BCMA CAR T cell therapy in newly diagnosed multiple myeloma patients
cellular therapy
clarithromycin
ejection fraction
car t-cell therapy
multiple myeloma
- 0 views
- 19 Feb, 2024